Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.
Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.
复制标题
DOI:
10.1007/s12195-015-0381-z
复制
发表时间:
2015
影响因子:
2.8
通讯作者:
King, Michael R.
中科院分区:
文献类型:
--
作者:
Li, Jiahe;Sharkey, Charles C.;Huang, Dantong;King, Michael R.
During metastasis, circulating tumor cells migrate away from a primary tumor via the blood circulation to form secondary tumors in distant organs. Mounting evidence from clinical observations indicates that the number of circulating tumor cells (CTCs) in the blood correlates with the progression of solid tumors before and during chemotherapy. Beyond the well-established role of CTCs as a fluid biopsy, however, the field of targeting CTCs for the prevention or reduction of metastases has just emerged. Conventional cancer therapeutics have a relatively short circulation time in the blood which may render the killing of CTCs inefficient due to reduced exposure of CTCs to drugs. Nevertheless, over the past few decades, the development of nanoparticles and nanoformulations to improve the half-life and release profile of drugs in circulation has rejuvenated certain traditional medicines in the emerging field of CTC neutralization. This review focuses on how the principles of nanomedicine may be applied to target CTCs. Moreover, inspired by the interactions between CTCs and host cells in the blood circulation, novel biomimetic approaches for targeted drug delivery are presented.
登录
查看更多内容
影响因子:
4.9
作者:
Alexis F;Pridgen E;Molnar LK;Farokhzad OC
通讯作者:
Farokhzad OC
影响因子:
3.7
作者:
Balasubramanian P;Lang JC;Jatana KR;Miller B;Ozer E;Old M;Schuller DE;Agrawal A;Teknos TN;Summers TA Jr;Lustberg MB;Zborowski M;Chalmers JJ
通讯作者:
Chalmers JJ
影响因子:
158.5
作者:
Cristofanilli, M;Budd, GT;Hayes, DF
通讯作者:
Hayes, DF
影响因子:
10.8
作者:
Champion, Julie A.;Katare, Yogesh K.;Mitragotri, Samir
通讯作者:
Mitragotri, Samir
影响因子:
3.7
作者:
Barnes, J. Matthew;Nauseef, Jones T.;Henry, Michael D.
通讯作者:
Henry, Michael D.